Sign in

CIK 0001368514

  • Large accelerated filer

ADMA BIOLOGICS, INC.

Sign in to watch
Ticker
ADMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
562590442
Phone
+1 201-478-5552
Business address
C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
Former names
R&R ACQUISITION VI, INC
  1. 4 Grant or award Director acquired 25,815 shares (grant or award)
  2. 4 Shares withheld for taxes President and CEO gave up 166,867 shares (to pay taxes)
  3. 4 Shares withheld for taxes EVP, CFO gave up 114,222 shares (to pay taxes)
  4. 4 Open-market buy EVP, CFO bought 6,993 shares at $2.86 ($20,000)
  5. 4 Open-market buy President and CEO bought 29,965 shares at $2.86 ($85,700)
  6. 4 Shares withheld for taxes President and CEO gave up 101,315 shares (to pay taxes)
  7. 4 Shares withheld for taxes EVP, CFO gave up 73,678 shares (to pay taxes)
  8. 4 Shares withheld for taxes EVP, CFO gave up 51,965 shares (to pay taxes)
  9. 4 Shares withheld for taxes President and CEO gave up 70,004 shares (to pay taxes)
  10. 4 Shares withheld for taxes EVP, CFO gave up 37,178 shares (to pay taxes)
  11. 4 Shares withheld for taxes President and CEO gave up 50,539 shares (to pay taxes)
  12. 4 Grant or award Director acquired 26,586 shares (grant or award)
  13. 4 Grant or award Director acquired 26,586 shares (grant or award)
  14. 4 Grant or award Director acquired 26,586 shares (grant or award)
  15. 4 Grant or award Director acquired 26,586 shares (grant or award)
  16. 4 Grant or award EVP, CFO acquired 137,500 shares (grant or award)
  17. 4 Grant or award Director acquired 26,586 shares (grant or award)
  18. 4 Grant or award President and CEO acquired 300,000 shares (grant or award)
  19. 4 Grant or award Director acquired 26,586 shares (grant or award)
  20. 4 Open-market buy Director bought 100,000 shares at $1.00 ($100,000)

Page 7 of 19 · 362 filings